Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Skin Diseases
>>
Daiichi Sankyo
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
patritumab
(U3-1287) / Amgen, Daiichi Sankyo
tigatuzumab
(CS-1008) / Daiichi Sankyo
tivantinib
(ARQ 197) / Daiichi Sankyo, Kyowa Kirin, Merck (MSD)
